Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion type Assertion NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_head.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_provenance.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion evidence source_evidence_literature NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_provenance.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion SIO_000772 19489767 NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_provenance.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion wasDerivedFrom befree-2016 NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_provenance.
- NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_assertion wasGeneratedBy ECO_0000203 NP742564.RAOgLBG0WI2OiEcrviPuoeraIow0dqrwv8rBzI2L3ynpI130_provenance.